ResMed (NYSE:RMD) launched NightOwl™, a home sleep apnea test that enhances user convenience with a small fingertip sensor and cloud data evaluation. Despite the broader market reacting negatively to ...

Resmed (RMD) announced its home sleep apnea test, NightOwl, is now available across the United States. NightOwl is an FDA-cleared home sleep ...

NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...

Leading health technology, Resmed, has announced its home sleep apnea test, NightOwl, is now available across the United States.

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD ... to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a ...

(RTTNews) - ResMed Inc.(RMD), announced Thursday that ... up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a comprehensive ...

Nunez, M.D., Chief Medical Officer at Resmed.“With NightOwl ... up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a ...

Resmed Inc. RMD recently launched its home sleep apnea test ... NightOwl is a disposable HSAT device that records up to 10 nights of sleep data for a single patient, including night-to-night ...